Tissue heart valves industry analysis

The global market for tissue heart valves will grow slowly over the forecast period and will post a moderate CAGR of almost 4% by 2020. The large-scale implementation of minimally invasive (MI) procedures will aid in the growth of this market during the forecast period. Physicians use invasive and MI procedures, such as sternotomy and thoracotomy, to implant tissue heart valves in people suffering from heart valve diseases. Since invasive procedures cause pleural effusion, arrhythmia, pleuritis, pericardial effusion, pericarditis, and infections in the lungs, physicians have been compelled to opt for MI surgeries for device implantation.

MI catheter-based procedures help improve the quality of life and are extremely safe. They also reduce the need for blood transfusions, the risk of infections, and hospital stays. This recent shift from open-heart procedures to MI methods will aid in the growth of this market until the end of 2020.

Tissue heart valves market drivers

An important factor that will spur the prospects for market growth is the rising preference for tissue heart valve replacement surgeries among the geriatric population. Recently, it has been observed that physicians perform tissue heart valve replacement surgeries to treat people who are aged 60 and above as they are at a high risk of developing complications. Mechanical heart valves can cause bleeding and increase the chances of reoperations in people of this age group. Since the use of tissue heart valves in people of this age group lowers the risks of bleeding, physicians are increasingly opting for this method as it helps to reduce the use of oral anticoagulation drugs for the management of bleeding complications.

Tissue heart valves market segmentation based on product

• Stented tissue heart valves
• Stentless tissue heart valves

The stented tissue heart valves segment dominated this market during 2015 as it accounted for a market share of more than more than 71%. Stented tissue heart valves are made from bovine or porcine heart tissues and are treated and mounted on an artificial stent. These artificial stents are metal or plastic stents with three posts surrounded by a sewing ring at the base. This sewing ring facilitates the secure fixation of the implanted graft in the valve annulus, whereas the valve ring diminishes the opening valve area of the graft.

Tissue heart valves market share based on geography 

• Americas
• APAC
• EMEA

In this market research, analysts have estimated the Americas to account for almost 41% of the total market share by 2020. The high incidence of heart valve diseases, such as such as aortic valve degeneration, and aortic stenosis, in this region, is a critical factor that will spur market growth until the end of the forecast period. Furthermore, a rise in the aging population will also augment the demand for tissue heart valves in the region.

Tissue heart valves market worth: Competitive landscape and key vendors

The global tissue heart valves market is consolidated and highly competitive owing to the presence of well-established vendors like Medtronic and Edwards Lifesciences. The well-established companies in this market have a strong brand name as they have the capability to offer a wide range of products. These vendors also have sizeable shares in the market, which, in turn, hinders the entry of new players.

Key vendors in the tissue heart valves market

• Edwards Lifesciences
• LivaNova
• Medtronic
• St. Jude Medical

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global tissue heart valves market?
• What are the key market trends impacting the growth of the global tissue heart valves market?
• What are the challenges to market growth?
• Who are the key vendors in the global tissue heart valves market?
• What are the market opportunities and threats faced by the vendors in the global tissue heart valves market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global tissue heart valves market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

• Global Left Atrial Appendage (LAA) Closure Market 2016-2020
• Global Cardiovascular Implants Market 2015-2019
• Global Peripherally Inserted Central Catheter Market 2015-2019
• Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market 2015-2019